Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-12-17 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
发行股份购买资产暨关联交易实施情况暨新增股份上市报告书
Capital/Financing Update Classification · 95% confidence The document is titled "中粮生物化学（安徽）股份有限公司 发行股份购买资产暨关联交易 实施情况暨新增股份上市报告书" which translates to "COFCO Biochemical (Anhui) Co., Ltd. Report on the Implementation of Issuance of Shares to Purchase Assets and Related Party Transactions and Listing of New Shares." The content details the issuance of shares to purchase assets, the approval and pricing of the share issuance, the listing of new shares, and related regulatory approvals. It includes detailed financial and transaction information about the asset acquisition and share issuance, including pricing, shareholder changes, and regulatory compliance. This is a comprehensive report on a capital transaction involving issuance of shares to purchase assets and related party transactions, including the listing of new shares. It is not a simple announcement or a brief summary but a detailed report on the transaction implementation and new share listing. Therefore, the document fits best under the category "Capital/Financing Update (CAP)" which covers updates on company fundraising, financing activities, or capital structure changes. The document is not an Annual Report, Audit Report, Earnings Release, or any other category. The length and detail confirm it is a full report, not just an announcement. Confidence is high due to the explicit focus on share issuance for asset purchase and listing of new shares.
2018-12-17 Chinese
关于发行股份购买资产相关方承诺事项的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 中粮生物化学（安徽）股份有限公司 regarding commitments related to the issuance of shares for asset acquisition. It includes multiple sections of formal commitments from the company, its controlling shareholders, and related parties about the authenticity of information, avoidance of competition, regulation of related-party transactions, share lock-up periods, and maintaining the independence of the listed company. The document references regulatory approvals from the China Securities Regulatory Commission and contains legal and compliance assurances related to a major asset restructuring transaction. It is not a financial report, earnings release, or management discussion but rather a formal disclosure of commitments and undertakings related to a capital transaction and asset acquisition. This type of document fits best under Capital/Financing Update (CAP) as it relates to issuance of shares and asset purchase commitments.
2018-12-17 Chinese
关于发行股份购买资产暨关联交易之发行结果暨股本变动的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance of shares by 中粮生物化学(安徽)股份有限公司 (COFCO Biochemical (Anhui) Co., Ltd.) as part of an asset purchase and related party transaction. It includes specifics on the number of shares issued, pricing, approvals from various regulatory bodies including the China Securities Regulatory Commission, and changes in shareholding structure. The document also discusses the completion of asset transfer, share registration, and includes opinions from independent financial advisors and legal counsel. The content focuses on the issuance of shares and capital structure changes related to a financing transaction rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2018-12-17 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of a significant shareholder (大耀香港有限公司) in 中粮生物化学(安徽)股份有限公司, including the reduction in shareholding percentage due to a non-public issuance of shares by the company. The document includes detailed information about the shareholder, the nature of the equity change, approvals from regulatory bodies, and the impact on shareholding percentages. It is a formal notification of a change in major shareholding levels, consistent with the definition of a Major Shareholding Notification (MRQ). The document is lengthy (over 12,000 characters) and contains substantive content about the shareholding change, not merely an announcement or a certification. Therefore, the appropriate classification is MRQ.
2018-12-17 Chinese
北京市君合律师事务所关于公司发行股份购买资产暨关联交易实施情况之法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the implementation of a share issuance to purchase assets and related party transactions by COFCO Biochemical (Anhui) Co., Ltd. It details the transaction overview, approvals, authorizations, implementation status, and legal compliance related to the issuance of shares for asset acquisition. The document is not a financial report, earnings release, or management discussion but a legal opinion on a specific transaction. It is not a regulatory announcement or a brief notice but a detailed legal opinion letter. This type of document fits best under the category of Capital/Financing Update (CAP), as it relates to issuance of shares and capital transactions. The document length (8197 characters) and content confirm it is a substantive legal opinion on a financing transaction rather than a simple announcement or certification.
2018-12-17 Chinese
2018年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the "2018 Fourth Extraordinary General Meeting of Shareholders" of the company. It details the meeting date, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, only the official announcement of the voting results and meeting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, not a full report or presentation.
2018-11-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.